nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.142	0.161	CbGeAlD
Flupentixol—DDC—nerve—amyotrophic lateral sclerosis	0.0663	0.0753	CbGeAlD
Flupentixol—DDC—hindbrain—amyotrophic lateral sclerosis	0.0497	0.0564	CbGeAlD
Flupentixol—DRD1—nerve—amyotrophic lateral sclerosis	0.0488	0.0553	CbGeAlD
Flupentixol—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0371	0.0421	CbGeAlD
Flupentixol—HTR2A—pons—amyotrophic lateral sclerosis	0.0366	0.0416	CbGeAlD
Flupentixol—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0312	0.0354	CbGeAlD
Flupentixol—DDC—embryo—amyotrophic lateral sclerosis	0.0311	0.0353	CbGeAlD
Flupentixol—DRD2—nerve—amyotrophic lateral sclerosis	0.0288	0.0327	CbGeAlD
Flupentixol—DDC—brainstem—amyotrophic lateral sclerosis	0.0285	0.0323	CbGeAlD
Flupentixol—HTR2A—appendage—amyotrophic lateral sclerosis	0.0268	0.0304	CbGeAlD
Flupentixol—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0244	0.0276	CbGeAlD
Flupentixol—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.022	0.025	CbGeAlD
Flupentixol—DRD2—hindbrain—amyotrophic lateral sclerosis	0.0216	0.0245	CbGeAlD
Flupentixol—DRD1—brainstem—amyotrophic lateral sclerosis	0.0209	0.0237	CbGeAlD
Flupentixol—HTR2A—nerve—amyotrophic lateral sclerosis	0.019	0.0216	CbGeAlD
Flupentixol—DDC—nervous system—amyotrophic lateral sclerosis	0.0149	0.0169	CbGeAlD
Flupentixol—DDC—central nervous system—amyotrophic lateral sclerosis	0.0144	0.0163	CbGeAlD
Flupentixol—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.0142	0.0161	CbGeAlD
Flupentixol—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0126	0.0143	CbGeAlD
Flupentixol—DRD2—brainstem—amyotrophic lateral sclerosis	0.0124	0.014	CbGeAlD
Flupentixol—DDC—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0118	0.11	CbGpPWpGaD
Flupentixol—DDC—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.0115	0.107	CbGpPWpGaD
Flupentixol—DDC—brain—amyotrophic lateral sclerosis	0.0114	0.0129	CbGeAlD
Flupentixol—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.0112	1	CrCbGaD
Flupentixol—DRD1—nervous system—amyotrophic lateral sclerosis	0.011	0.0124	CbGeAlD
Flupentixol—DRD1—central nervous system—amyotrophic lateral sclerosis	0.0106	0.012	CbGeAlD
Flupentixol—HTR2A—embryo—amyotrophic lateral sclerosis	0.0089	0.0101	CbGeAlD
Flupentixol—DRD1—brain—amyotrophic lateral sclerosis	0.00838	0.00951	CbGeAlD
Flupentixol—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00816	0.00925	CbGeAlD
Flupentixol—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00804	0.00913	CbGeAlD
Flupentixol—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00774	0.00879	CbGeAlD
Flupentixol—DDC—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00728	0.0679	CbGpPWpGaD
Flupentixol—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00661	0.0075	CbGeAlD
Flupentixol—DRD2—nervous system—amyotrophic lateral sclerosis	0.00648	0.00735	CbGeAlD
Flupentixol—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00636	0.00722	CbGeAlD
Flupentixol—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00624	0.00708	CbGeAlD
Flupentixol—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00622	0.00706	CbGeAlD
Flupentixol—CHRM1—brain—amyotrophic lateral sclerosis	0.00615	0.00698	CbGeAlD
Flupentixol—DRD2—cerebellum—amyotrophic lateral sclerosis	0.0061	0.00692	CbGeAlD
Flupentixol—ABCB1—embryo—amyotrophic lateral sclerosis	0.00583	0.00662	CbGeAlD
Flupentixol—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00569	0.00645	CbGeAlD
Flupentixol—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00507	0.00575	CbGeAlD
Flupentixol—ADRA1A—brain—amyotrophic lateral sclerosis	0.00505	0.00573	CbGeAlD
Flupentixol—DRD2—brain—amyotrophic lateral sclerosis	0.00495	0.00562	CbGeAlD
Flupentixol—DDC—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0047	0.0438	CbGpPWpGaD
Flupentixol—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00427	0.00485	CbGeAlD
Flupentixol—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00411	0.00467	CbGeAlD
Flupentixol—DRD1—Hypothetical Network for Drug Addiction—GRIA2—amyotrophic lateral sclerosis	0.00409	0.0381	CbGpPWpGaD
Flupentixol—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00402	0.00456	CbGeAlD
Flupentixol—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00373	0.00423	CbGeAlD
Flupentixol—ADRA1A—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.0037	0.0345	CbGpPWpGaD
Flupentixol—DDC—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00344	0.0321	CbGpPWpGaD
Flupentixol—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00332	0.00377	CbGeAlD
Flupentixol—HTR2A—brain—amyotrophic lateral sclerosis	0.00327	0.00371	CbGeAlD
Flupentixol—DRD2—Hypothetical Network for Drug Addiction—GRIA2—amyotrophic lateral sclerosis	0.00309	0.0288	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00281	0.0262	CbGpPWpGaD
Flupentixol—ABCB1—nervous system—amyotrophic lateral sclerosis	0.0028	0.00318	CbGeAlD
Flupentixol—DDC—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00272	0.0253	CbGpPWpGaD
Flupentixol—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.0027	0.00306	CbGeAlD
Flupentixol—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00263	0.00299	CbGeAlD
Flupentixol—DRD1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00245	0.0229	CbGpPWpGaD
Flupentixol—ABCB1—brain—amyotrophic lateral sclerosis	0.00214	0.00243	CbGeAlD
Flupentixol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00189	0.0176	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00185	0.0173	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00181	0.0169	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0169	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00181	0.0169	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00181	0.0169	CbGpPWpGaD
Flupentixol—DDC—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.00145	0.0135	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00125	0.0116	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00109	0.0102	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000937	0.00873	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.000826	0.0077	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000702	0.00655	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000702	0.00655	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000702	0.00655	CbGpPWpGaD
Flupentixol—DDC—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00069	0.00643	CbGpPWpGaD
Flupentixol—DDC—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00069	0.00643	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000652	0.00607	CbGpPWpGaD
Flupentixol—DDC—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000631	0.00588	CbGpPWpGaD
Flupentixol—DDC—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000587	0.00547	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000583	0.00544	CbGpPWpGaD
Flupentixol—DDC—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000551	0.00514	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000542	0.00505	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000514	0.00479	CbGpPWpGaD
Flupentixol—DDC—Metabolism—DAO—amyotrophic lateral sclerosis	0.000499	0.00465	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000492	0.00459	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000481	0.00449	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000475	0.00443	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000468	0.00436	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000467	0.00436	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000412	0.00384	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000409	0.00381	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000402	0.00375	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.0004	0.00373	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000397	0.0037	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000394	0.00367	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000378	0.00352	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000376	0.00351	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000363	0.00339	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GSR—amyotrophic lateral sclerosis	0.000349	0.00325	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000332	0.0031	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000327	0.00305	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000317	0.00296	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000311	0.0029	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000306	0.00286	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000305	0.00284	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.0003	0.0028	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000299	0.00278	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000286	0.00267	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000272	0.00254	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000245	0.00228	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000236	0.0022	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000233	0.00217	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000231	0.00215	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000225	0.00209	CbGpPWpGaD
Flupentixol—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000219	0.00204	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000212	0.00197	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000197	0.00183	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000194	0.00181	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000193	0.0018	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000186	0.00173	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000182	0.00169	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00018	0.00168	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000179	0.00166	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000176	0.00164	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000176	0.00164	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000175	0.00164	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000175	0.00163	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000173	0.00161	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000172	0.00161	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000172	0.0016	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00017	0.00158	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000168	0.00157	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000168	0.00157	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000167	0.00156	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000165	0.00154	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00016	0.00149	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000157	0.00147	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000156	0.00146	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000155	0.00145	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000154	0.00144	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000154	0.00144	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000154	0.00143	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000154	0.00143	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000149	0.00139	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000149	0.00139	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000147	0.00137	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000143	0.00133	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000142	0.00133	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.00132	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000136	0.00127	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000135	0.00125	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000134	0.00125	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000133	0.00124	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000133	0.00124	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000131	0.00122	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000128	0.00119	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000126	0.00118	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000126	0.00118	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000125	0.00117	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000125	0.00116	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000123	0.00114	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000122	0.00114	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000122	0.00113	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00012	0.00112	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000117	0.00109	CbGpPWpGaD
Flupentixol—DDC—Metabolism—APOE—amyotrophic lateral sclerosis	0.000116	0.00108	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000115	0.00107	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000115	0.00107	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000113	0.00105	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000111	0.00104	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000109	0.00102	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000109	0.00101	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000108	0.001	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000107	0.000997	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000106	0.000986	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000105	0.000981	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000105	0.000975	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.000975	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000104	0.000966	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000102	0.000948	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.71e-05	0.000905	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.66e-05	0.0009	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.55e-05	0.00089	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.45e-05	0.000881	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.44e-05	0.00088	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.39e-05	0.000876	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.34e-05	0.000871	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.29e-05	0.000866	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.24e-05	0.000861	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.24e-05	0.000861	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.22e-05	0.00086	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.2e-05	0.000857	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.1e-05	0.000848	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.59e-05	0.000801	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	8.51e-05	0.000793	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.24e-05	0.000768	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.06e-05	0.000751	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.98e-05	0.000743	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.89e-05	0.000736	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.77e-05	0.000724	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.73e-05	0.00072	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.68e-05	0.000716	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.67e-05	0.000715	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.6e-05	0.000709	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.56e-05	0.000705	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.52e-05	0.000701	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.4e-05	0.00069	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.99e-05	0.000651	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.98e-05	0.00065	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.86e-05	0.00064	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.83e-05	0.000636	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.72e-05	0.000626	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.57e-05	0.000612	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.49e-05	0.000605	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.38e-05	0.000595	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.35e-05	0.000592	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.25e-05	0.000583	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.23e-05	0.000581	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.18e-05	0.000576	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.08e-05	0.000567	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.99e-05	0.000558	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.95e-05	0.000555	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.86e-05	0.000546	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.79e-05	0.00054	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.7e-05	0.000531	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.67e-05	0.000529	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.58e-05	0.00052	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.46e-05	0.000509	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.08e-05	0.000474	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.96e-05	0.000462	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.88e-05	0.000455	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.85e-05	0.000452	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.78e-05	0.000445	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.66e-05	0.000435	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.59e-05	0.000428	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.56e-05	0.000425	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.49e-05	0.000419	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.2e-05	0.000391	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.12e-05	0.000384	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.05e-05	0.000378	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.03e-05	0.000376	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.97e-05	0.00037	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.84e-05	0.000358	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.77e-05	0.000352	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.76e-05	0.00035	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.75e-05	0.00035	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.7e-05	0.000345	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.45e-05	0.000322	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.23e-05	0.000301	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.17e-05	0.000296	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.12e-05	0.000291	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.1e-05	0.000289	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.05e-05	0.000285	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.05e-05	0.000285	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.84e-05	0.000265	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.74e-05	0.000256	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.44e-05	0.000227	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.4e-05	0.000224	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.39e-05	0.000223	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.35e-05	0.000219	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.31e-05	0.000215	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.27e-05	0.000212	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.26e-05	0.00021	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.22e-05	0.000207	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.07e-05	0.000193	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.07e-05	0.000193	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.04e-05	0.00019	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.03e-05	0.000189	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.99e-05	0.000186	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.000181	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.56e-05	0.000146	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.54e-05	0.000144	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	0.000143	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.51e-05	0.000141	CbGpPWpGaD
